Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Larisa Moerman"'
Autor:
Bruce Warshavsky, Itamar Grotto, Isabella Karakis, Emilia Anis, Gary M. Ginsberg, Esther Marva, Paul E. Slater, Ruslan Gosinov, Larisa Moerman
Publikováno v:
Journal of Public Health Policy. 39:304-317
Pertussis is the only vaccine-preventable disease that has re-emerged in Israel. In the last two decades, despite high primary immunization coverage, crude incidence increased over tenfold, with especially high morbidity among infants and adolescents
Autor:
Dan Yamin, Shai Gertler, Dean Langsam, Emilia Anis, Erlyn Rachelle King Macarayan, Alison P. Galvani, Meagan C. Fitzpatrick, Itamar Grotto, Larisa Moerman, Erez Shmueli
Publikováno v:
SSRN Electronic Journal.
Autor:
Larisa Moerman, Boaz Lev, Itamar Grotto, Ehud Kaliner, Paul E. Slater, Bruce Warshavsky, Emilia Anis
Publikováno v:
Journal of Public Health Policy. 34:288-301
Since 1996, after the full institution of the two-dose measles, mumps, and rubella vaccine (MMR) regimen in Israel, rubella incidence has declined dramatically and has remained extremely low. Cyclical outbreaks ended; the two brief outbreaks that did
Autor:
Eran Kopel, Eli Somekh, Tamy Shohat, Alex Leventhal, Ravit Bassal, Ehud Kaliner, Lisa Rubin, Ella Mendelson, Shepherd Roee Singer, Jacob Moran-Gilad, Shmuel Rishpon, Danit Sofer, Yossi Manor, Itamar Grotto, Diana Tasher, Mira Honovich, Emilia Anis, Lester M. Shulman, Michael Gdalevich, Ronni Gamzu, Larisa Moerman, Boaz Lev
Publikováno v:
The Lancet. Infectious diseases. 15(10)
Summary In 2013, a silent wild poliovirus type 1 importation and sustained transmission event occurred in southern Israel. With the aim of preventing clinical poliomyelitis and ensuring virus re-elimination, the public health response to the importat
Publikováno v:
Epidemiology and infection. 140(3)
SUMMARYMumps outbreaks in recent years have given rise to questions about the effectiveness of the mumps vaccine. This study examined the epidemiological data from a recent mumps outbreak in Israel and from outbreaks in other countries with high vacc
Autor:
Pamela Rendi-Wagner, Manfred S. Green, Dani Cohen, Sophy Goren, Ravit Bassal, Larisa Moerman, Joshua Tobias
Publikováno v:
Vaccine. 28(19)
This study was undertaken to estimate the magnitude of Bordetella pertussis infections in a highly vaccinated population in Israel in order to evaluate the relationship between clinical notification data and serology-based evidence of infection. A cr
Autor:
Bruce Warshavsky, Avi Israeli, Paul E. Slater, Emilia Anis, Itamar Grotto, Larisa Moerman, Boaz Lev
Publikováno v:
The Journal of infection. 59(4)
Summary Background Despite success in controlling measles through a national immunization program, Israel recently experienced its largest measles outbreak since 1994. Methods Using data reported by health district offices to the Ministry of Health,
Publikováno v:
The Israel Medical Association journal : IMAJ. 8(5)
Pertussis is the only vaccine-preventable disease that has re-emerged in Israel. The reported crude incidence of the disease increased 16-fold since 1998.To describe the epidemiology of pertussis and explain the substantial increase in reported pertu
Autor:
Asher Ornoy, Alona Aharonovich, Orna Diav-Citrin, Rebecka Wajnberg, Svetlana Shechtman, Larisa Moerman, Judy Arnon
Publikováno v:
The Journal of allergy and clinical immunology. 111(6)
Background: Loratadine is a second-generation histamine H 1 -receptor antagonist, used in the treatment of allergic conditions. No prospective controlled trials on loratadine in human pregnancy have been published to date. Objective: To determine whe